bupropion has been researched along with Eosinophilia in 3 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To the best of our knowledge, this is the third published case of bupropion-related eosinophilia." | 7.79 | Eosinophilia associated with bupropion. ( Aguirre, C; Etxegarai, E; García, M; Lertxundi, U; Ruiz, B, 2013) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 7.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "To describe the first incidence of eosinophilia following administration of bupropion." | 7.69 | Eosinophilia associated with bupropion. ( Housel, GJ; Mahowald, JA; Malesker, MA; Malone, PM; Soori, GS, 1995) |
| "To the best of our knowledge, this is the third published case of bupropion-related eosinophilia." | 3.79 | Eosinophilia associated with bupropion. ( Aguirre, C; Etxegarai, E; García, M; Lertxundi, U; Ruiz, B, 2013) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 3.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "To describe the first incidence of eosinophilia following administration of bupropion." | 3.69 | Eosinophilia associated with bupropion. ( Housel, GJ; Mahowald, JA; Malesker, MA; Malone, PM; Soori, GS, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, M | 1 |
| Ruiz, B | 1 |
| Aguirre, C | 1 |
| Etxegarai, E | 1 |
| Lertxundi, U | 1 |
| Bagshaw, SM | 1 |
| Cload, B | 1 |
| Gilmour, J | 1 |
| Leung, ST | 1 |
| Bowen, TJ | 1 |
| Malesker, MA | 1 |
| Soori, GS | 1 |
| Malone, PM | 1 |
| Mahowald, JA | 1 |
| Housel, GJ | 1 |
3 other studies available for bupropion and Eosinophilia
| Article | Year |
|---|---|
Eosinophilia associated with bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cough; Depressive Disorder; Eosinophilia; Femal | 2013 |
Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Canada; Eosinophilia; Exanthema; Hepatit | 2003 |
Eosinophilia associated with bupropion.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Depression; Eosinophilia; Female; Humans; | 1995 |